Floating microspheres of cimetidine: Formulation, characterization and in vitro evaluation

Acta Pharmaceutica

Volumn 55, Issue 3, 2005, Pages 277-285

  Srivastava, Anand Kumar ^a   Ridhurkar, Devendra Narayanrao ^a   Wadhwa, Saurabh ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Bioavailability; Cimetidine; Floating microspheres; In vitro release

Indexed keywords

ANTIHISTAMINIC AGENT; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYPROPYLMETHYLCELLULOSE; MICROSPHERE; POLYMER; SOLVENT;

ARTICLE; BIOAVAILABILITY; CHEMICAL COMPOSITION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SCREENING; GASTROINTESTINAL TRACT; HYDRODYNAMICS; IN VITRO STUDY; PARTICLE SIZE; RELIABILITY; SCANNING ELECTRON MICROSCOPY;

EID: 27144553775     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. P. R. Seth and J. Tossounian, The hydrodynamically balanced system HBS™: A novel drug delivery system for oral use, Drug Dev. Ind. Pharm. 10 (1984) 313-339.
2. A. J. Moes, Gastroretentive dosage forms, Crit. Rev. Ther. Drug Carrier Syst. 10 (1993) 143-195.
3. A. A. Deshpande, C. T. Rhodes, N. H. Shah and A. W. Malick, Controlled-release drug delivery systems for prolonged gastric residence: an overview, Drug Dev. Ind. Pharm. 22 (1996) 531-539.
4. L. Whitehead, J. T. Fell, J. H. Collett, H. L. Sharma and A. M. Smith, Floating dosage forms: an in vivo study demonstrating prolonged gastric retention, J. Control. Rel. 55 (1998) 3-12.
5. R. Talukder and R. Fassihi, Gastroretentive delivery systems: a mini review, Drug Dev. Ind. Pharm. 30 (2004) 1019-1028.
6. N. Rouge, J. C. Leroux, E. T. Cole, E. Doelker and P. Buri, Prevention of the sticking tendency of floating minitablets filled into hard gelatin capsules, Eur. J. Pharm. Biopharm. 43 (1997) 165-171.
7. Y. Sato, Y. Kawashima, H. Takeuchi and H. Yamamoto, In vivo evaluation of riboflavin-containing microballoons for floating controlled drug delivery system in healthy human volunteers, J. Control. Rel. 93 (2003) 39-47.
8. Y. Kawashima, T. Niwa, H. Takechi, T. Hino and Y. Itoh, Hollow microspheres for use as floating controlled drug delivery systems in the stomach, J. Pharm. Sci. 81 (1992) 135-140.
9. K. S. Soppimath, A. R. Kulkarni, W. E. Rudzinski and T. M. Aminabhavi, Microspheres as floating drug-delivery systems to increase gastric retention of drugs, Drug Metab. Rev. 33 (2002) 149-160.
10. K. Muthusamy, G. Govindarazan and T. K. Ravi, Preparation and evaluation of lansoprazole floating micropellets, Ind. J. Pharm. Sci. 67 (2005) 75-79.
11. B. C. Thanoo, M. C. Sunny and A. Jayakrishnan, Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid, J. Pharm. Pharmacol. 45 (1993) 21-24.
12. N. J. Joseph, S. Lakshmi and A. Jayakrishnan, A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits, J. Control. Rel. 79 (2002) 71-79.
13. S. Stithit, W. Chen and J. C. Price, Development and characterization of buoyant theophylline microspheres with near zero order release kinetics, J. Microencaps. 15 (1998) 725-737.
14. J. H. Lee, T. G. Park and H. K. Choi, Development of oral drug delivery system using floating microspheres, J. Microencaps. 16 (1999) 715-729.
15. U. Gladiziwa and U. Klotz, Pharmacokinetics and pharmacodynamics of H2 receptor antagonists in patients with renal insufficiency, Clin. Pharmacokinet. 24 (1993) 319-332.
16. A. Struebel, J. Siepmann and R. Bodmeier, Multiple units gastroretentive drug delivery systems: a new preparation method for low density microspheres, J. Microencaps. 20 (2003) 329-347.
17. The United States Pharmacopoeia XXIV, United States Pharmacopoeial Convention, Rockville 2000, pp. 1941-1943.
18. B. N. Singh and K. H. Kim, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, J. Control. Rel. 63 (2000) 235-259.
19. R. Dinarvand, S. Mirfattahi and F. Atyabi, Preparation, characterization and in vitro drug release of isosorbide dinitrate microspheres, J. Microencaps. 19 (2002) 73-81.
20. S. Abrol, A. Trehan and O. P. Katare, Formulation, characterization, and in vitro evaluation of silymarin-loaded lipid microspheres, Drug Deliv. 11 (2004) 185-191.
21. B. P. Reddy, A. K. Dorle and D. K. Krishna, Albumin microspheres: effect of process variables on the distribution and in vitro release, Drug Dev. Ind. Pharm. 16 (1990) 1781-1803.
22. T. Ishizaka, Preparation of egg albumin microspheres and microcapsules, J. Pharm. Sci. 70 (1981) 358-361.
23. J. H. Ratcliffe, I. M. Hunney Ball, C. G. Wilson, A. Smith and S. S. Davis, Albumin microspheres for intra articular drug delivery: investigation of their retention in normal and arthritic knee joints of rabbits, J. Pharm. Pharmacol 39 (1987) 290-315.
24. P. Costa and J. M. S. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 39 (1987) 39-45.
25. J. G. Wagner, Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules, J. Pharm. Sci. 58 (1969) 1253-1257.
26. E. Schefter and T. Higuchi, Dissolution behavior of crystalline solvated and non-solvated forms of some pharmaceuticals, J. Pharm. Sci. 52 (1963) 781-791.